For the first time, scientists are testing whether a first-of-its-kind drug inspired by spider venom can reverse the tissue damage caused by a heart attack. Starting next summer, the team plans to test the safety of the molecule in a clinical trial in Australia.
The molecule, a small protein called Hi1a, mimics one made by Australian funnel-web spiders. It works by preventing heart tissue from becoming too acidic during a heart attack.
